Why Does Hormonal Acne Keep Coming Back? Here's What Doctors Investigate

Hormonal acne is not a single condition. It is a clinical finding that points to one or more underlying drivers, and the treatment route that works depends entirely on which driver is actually in play. A dermatologist's first job is not to prescribe, it is to investigate.

Androgens, testosterone and its more potent derivative dihydrotestosterone, stimulate the sebaceous glands to produce more sebum. When sebum output outpaces the skin's ability to clear it, the follicle becomes a hospitable environment for Cutibacterium acnes, the bacterium central to inflammatory acne lesions. This is the basic mechanism. What varies is why androgen activity is elevated or why the sebaceous glands are responding to it disproportionately.

The pattern of breakouts gives the first clue. Acne that clusters along the jawline, chin, and lower cheeks, worsens in the week before menstruation, and clears partially in the follicular phase is the classic hormonal distribution. But this pattern is not diagnostic on its own. Fungal acne, perioral dermatitis, and contact reactions can mimic it. A dermatologist distinguishes these before attributing the presentation to hormones.

The clinical history comes before any test. A dermatologist will ask about cycle regularity, the timing of flares relative to the cycle, contraceptive use, recent changes in stress load, sleep, or diet, and whether the acne began or worsened after stopping hormonal contraception. That last detail matters: post-pill acne is a recognised pattern that often resolves within six to twelve months without systemic intervention.

If the history suggests an androgen excess rather than normal androgen sensitivity, blood work follows. The panel typically includes total and free testosterone, DHEA-S, and sometimes prolactin and thyroid function. Elevated DHEA-S points toward an adrenal source. Elevated free testosterone with a low sex hormone-binding globulin level is the more common picture in polycystic ovary syndrome. A dermatologist cannot diagnose PCOS, that requires a gynaecologist or endocrinologist, but they can identify when the skin picture warrants a referral.

Not every patient with hormonal acne has measurable androgen excess. Many have androgen levels within the normal reference range but sebaceous glands that are more sensitive to those levels. This is a receptor-level phenomenon, not a hormone-level one, and it does not show up in blood work. The clinical pattern and the treatment response are what guide the decision in these cases.

Once the investigation is complete, the treatment route follows the finding. There is no universal first-line option for hormonal acne.

Topical retinoids remain the backbone of acne treatment regardless of cause. They normalise follicular keratinisation, the process by which dead skin cells shed inside the pore, and reduce the environment in which acne bacteria thrive. A dermatologist will often stabilise the skin with a retinoid before adding anything systemic, because a retinoid response tells them how much of the acne burden is structural rather than hormonal.

When the hormonal component is clear and topical treatment is insufficient, oral options enter the picture. Combined oral contraceptives containing an anti-androgenic progestogen are one route for those who are appropriate candidates, they suppress ovarian androgen production and raise sex hormone-binding globulin, which reduces free testosterone. Spironolactone, an aldosterone antagonist that also blocks androgen receptors in the skin, is another option used in some clinical settings; it is not universally available or approved for acne across all markets, and its use requires monitoring. Neither of these is a dermatologist's decision alone when a patient has a complex hormonal history, endocrinology input is often part of the picture.

Low-dose oral antibiotics are sometimes used in the short term to reduce the inflammatory load while other treatments establish themselves. They do not address the hormonal driver and are not appropriate as a long-term standalone treatment.

Hormonal treatment routes are not appropriate for everyone presenting with lower-face acne. Patients who are pregnant, planning a pregnancy, or breastfeeding require a different approach entirely, this is a conversation to have with both a dermatologist and an obstetrician, not a decision to make based on general guidance. Those with a history of certain cardiovascular conditions may not be candidates for combined oral contraceptives. And patients whose acne is primarily comedonal rather than inflammatory may find that hormonal interventions have limited effect, because the driver in that presentation is often different.

Self-treating suspected hormonal acne with supplements marketed as hormone balancers, spearmint, DIM, vitex, is not equivalent to clinical management. Some have preliminary evidence behind them; none has the evidence base of established prescription routes, and using them in place of investigation means the underlying cause goes unaddressed. A dermatologist is the right starting point, not a substitute for one.

Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!